NEW YORK (GenomeWeb News) — TriLink BioTechnologies will provide Osmetech Molecular Diagnostics with reagents for its new cystic fibrosis and warfarin sensitivity tests, TriLink said today.
TriLink said it will provide Osmetech with custom oligonucleotides required for its eSensor Cystic Fibrosis Carrier Detection System and its eSensor XT-8 System for warfarin sensitivity.
San Diego-based TriLink makes custom oligonucleotides, nucleoside triphosphates, and PCR products for the diagnostic and OEM markets.
Financial terms of the agreement were not released.